CTRI/2025/10/096147RecruitingNot Applicable
Assessment of patient satisfaction ease of training and clinical effectiveness of ICS-LABA combinations delivered through Ciphaler A real world observational study in patients with asthma CONTROL STUDY
Trial Snapshot
- Phase
- Not Applicable
- Status
- Recruiting
- Sponsor
- Cipla Ltd
- Enrollment
- 2,500
- Locations
- 3
- Primary Endpoint
- Patient satisfaction
Study Overview
Brief Summary
Drugs administered through the inhaled route have become very important for the treatment of respiratory diseases like asthma. This is a real-world, observational study to assess patient satisfaction, ease of training and clinical effectiveness of ICS-LABA combinations delivered through Ciphaler® in patients with asthma.
Study Design
- Study Type
- Observational
Eligibility Criteria
- Ages
- 18.00 Year(s) to 99.00 Year(s) (—)
- Sex
- All
Inclusion Criteria
- •1 Either gender, of age 18 years or above, with documented diagnosis of Asthma (as per GINA 2025) 2 Prescribed treatment with ICS-LABA delivered through the Ciphaler® based on investigator discretion 3 Willing for follow-up at scheduled visit as per protocol 4 A voluntarily given written, signed, dated informed consent from participants and/or legally acceptable representative.
Exclusion Criteria
- •1 Hypersensitivity to the study drug or any of its components 2 Life-threatening or unstable respiratory disease, including lower respiratory tract infection, within the past 4 weeks from screening 3 Acute episodes of asthma requiring systemic corticosteroids, emergency care or hospitalization in the 30 days prior to Baseline visit 4 Chronic pulmonary diseases other than asthma such as COPD, post-tuberculosis lung disease, pulmonary fibrotic disease, or pulmonary arterial hypertension 5 Severe asthma patients receiving biologicals.
Outcomes
Primary Outcomes
Patient satisfaction
Time Frame: 8 weeks
Secondary Outcomes
- 1. Ease of training with Ciphaler®
- 2. Change in ACQ-5 score(Baseline)
- 3. Change in ACQ-5 score categories as well controlled (ACQ-5 less than 0.75), partially controlled (ACQ-5 more than 0.75 to less than 1.5), and uncontrolled (ACQ-5 more than 1.5)(Baseline)
- 4. Adverse Event(Through Study)
Investigators
Dr Sundeep Salvi
Chest Research and Training Private Limited
Study Sites (3)
Loading locations...
Similar Trials
Completed
Unknown
Comparison of the effects of two different General anaesthesia agents in adult patients undergoing General anaesthesia with airway MaskCTRI/2025/09/094814Department of Anesthesiology60
Completed
Not Applicable
Evaluating inhaler use technique and satisfaction with inhaler devices in Japanese patients with COPDJPRN-UMIN000033527Juntendo University155
Recruiting
Not Applicable
The Effect of İnhaler Training and Reminders on Medication on Adherence in Elderly IndividualsNCT07381166Çanakkale Onsekiz Mart University64
Recruiting
Not Applicable
Effect of Tegileridine Versus Sufentanil as Analgesic Components on Opioid-Induced Cough During Anesthesia InductionNCT07323043The First People's Hospital of Lianyungang190
Not yet recruiting
Not Applicable
The Effectiveness of an Innovative Inhalation Training Device in Improving Medication Accuracy, Dyspnea, and Quality of Life in Elderly Patients With Chronic Obstructive Pulmonary DiseaseChronic Obstructive Pulmonary DiseaseNCT07305649Taipei Veterans General Hospital, Taiwan82